ETS2 and prostate carcinoma: For example, Ets2 amplification has also been demonstrated in patients with acute nonlymphoblastic leukaemia [9], and Ets2 is expressed at elevated levels in breast, ocular neoplasm, cervical and prostate cancer [10–13].